Sutton Wealth Advisors Inc. Novavax Inc Transaction History

Sutton Wealth Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$5.76 - $12.48 $3,985 - $8,636	-692 Closed	0 $0
Q4 2022 Nov 07, 2023	BUY	$8.86 - $25.04 $6,131 - $17,327	692 New	692 $7.11 Million
Q3 2022 Nov 07, 2023	SELL	$18.2 - $76.12 $400 - $1,674	-22 Closed	0 $0
Q2 2022 Nov 07, 2023	BUY	$36.28 - $75.29 $798 - $1,656	22 New	22 $1.13 Million
Q1 2022 Nov 07, 2023	SELL	$69.73 - $142.9 $348 - $714	-5 Closed	0 $0
Q4 2021 Nov 07, 2023	SELL	$134.56 - $217.97 $134 - $217	-1 Reduced 16.67%	5 $715,000
Q3 2021 Nov 07, 2023	BUY	$177.8 - $270.58 $1,066 - $1,623	6 New	6 $1.24 Million

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.